Anti-HIV drug cuts infection risk 90% – Irish Times

WASHINGTON – A US Food and Drug Administration (FDA) panel of outside experts has recommended Gilead Sciences Inc’s Truvada as a treatment for preventing HIV infection among people at risk of contracting Aids, including homosexual and bisexual men.